Related Experiment Video
Updated: Mar 20, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.4K
Optimal Individualized Treatments in Resource-Limited Settings
The International Journal of Biostatistics
|May 27, 2016
Summary
This study introduces optimal individualized treatment rules (ITRs) for limited treatment resources. It provides new formulas for optimal stochastic and deterministic ITRs, enhancing treatment allocation strategies.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Health Economics
Background:
- Individualized Treatment Rules (ITRs) optimize patient outcomes by tailoring treatments to covariates.
- Existing optimal ITR methods assume unlimited treatment resources, which is often unrealistic.
- Resource limitations necessitate new approaches to optimal ITR development.
Purpose of the Study:
- To develop methods for finding optimal Individualized Treatment Rules (ITRs) under resource constraints.
- To derive closed-form expressions for optimal stochastic and deterministic ITRs in limited resource settings.
- To propose an efficient estimator for mean outcomes under optimal stochastic ITRs.
Main Methods:
- Derivation of a general closed-form expression for an optimal stochastic ITR.
- Derivation of a closed-form expression for an optimal deterministic ITR under specific assumptions.
- Development of a semiparametric estimator for mean outcomes under optimal stochastic ITRs.
Main Results:
- A general closed-form expression for optimal stochastic ITRs in resource-limited settings is provided.
- A closed-form expression for optimal deterministic ITRs is derived under an additional assumption.
- An efficient estimator for mean outcomes under optimal stochastic ITRs is presented and validated through simulations.
Conclusions:
- The study provides novel theoretical frameworks and practical tools for optimizing treatment strategies when resources are limited.
- The proposed methods and estimators are efficient and applicable in large semiparametric models.
- This work advances the field of personalized medicine by addressing the critical issue of treatment resource allocation.
Related Concept Videos
Dosage Regimen: Individualization
265
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
265
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine
1.7K
1.7K
Dosage Regimens: Designs and Approaches
449
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
449
Dosage Regimens: Partial Pharmacokinetic Parameters
247
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
247
Therapeutic Drug Monitoring: Affecting Factors
318
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
318

